Principal Investigator
Amer Beitinjaneh
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20241277
Clinical Trial Summary
A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Leukemia
Contact Information
Phone Number
305-243-2647